Abstract
Lipopolysaccharide (LPS) is a major component of the meningococcal outer membrane. It consists of a hexa-acylated glucosamine disaccharide substituted at both ends with diphosphoethanolamine, to which an oligosaccharide chain of up to 10 sugar residues is attached (1,2). It lacks a long repeating O-antigen side chain, as is typically found in many Enterobacteriaceae, and is therefore also sometimes referred to as lipooligosaccharide or LOS. The oligosaccharide part shows structural variation among strains, which forms the basis for division into the different immunotypes L1 to L12 (3). In addition, individual strains can vary their LPS structure through high-frequency phase variation of several genes encoding glycosyltransferases (4). This can affect virulence-related properties such as invasion of host cells and serum resistance (5). In the context of vaccine development, meningococcal LPS is relevant in several ways. First, the cell surface-exposed oligosaccharide part may contain epitopes recognized by bactericidal or otherwise protective antibodies; however, the presence of host-identical structures such as the terminal lacto-N-neotetraose means that the possibility of inducing autoimmune pathology should also be considered (6). Second, the membrane-anchoring lipid A part has strong endotoxin activity, by inducing the synthesis of proinflammatory cytokines in a variety of host cells (7). This plays a major role in the pathological manifestations of meningococcal sepsis, and is also responsible for most of the reactogenicity found with outer membrane vesicle (OMV)-based vaccines.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Kulshin, V. A., Zähringer, U., Lindner, B., Frasch, C. E., Tsai, C.-M., Dmitriev, B. A., and Rietschel, E. T. (1992) Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J. Bacteriol. 174, 1793–1800.
Pavliak, V., Brisson, J.-R., Michon, F., Uhrin, D., and Jennings, H. J. (1993) Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis. J. Biol. Chem. 268, 14146–14152.
Scholten, R. J. P. M., Kuipers, B., Valkenburg, H. A., Dankert, J., Zollinger, W. D., and Poolman, J. T. (1994) Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J. Med. Microbiol. 41, 236–243.
Jennings, M. P., Hood, D. W., Peak, I. R. A., Virji, M., and Moxon, E. R. (1995) Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol. Microbiol. 18, 729–740.
van Putten, J. P. M. and Robertson, B. D. (1995) Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria. Mol. Microbiol. 16, 847–853.
Tsai, C.-M. and Civin, C. I. (1991) Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal 1-4GlcNAc 1-3Gal 1-4Glc). Infect. Immun. 59, 3604–3609.
Zähringer, U., Lindner, B., and Rietschel, E. T. (1994) Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides, in Advances in Carbohydrate Chemistry and Biochemistry, vol. 50 (Horton, D., ed.), Academic Press, Inc., San Diego, pp. 211–276.
Steeghs, L., den Hartog, R., den Boer, A., Zomer, B., Roholl, P., and van der Ley, P. (1998) Meningitis bacterium is viable without endotoxin. Nature 392, 449–450.
van der Ley, P., Kramer, M., Martin, A., Richards, J. C., and Poolman, J. T. (1997) Analysis of the icsBA locus required for biosynthesis of the inner core region from Neisseria meningitidis lipopolysaccharide. FEMS Microbiol. Lett. 146, 247–253.
Jennings, M. P., van der Ley, P., Wilks, K. E., Maskell, D. J., Poolman, J. T., and Moxon, E. R. (1993) Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis. Mol. Microbiol. 10, 361–369.
Lee, F. K. N., Stephens, D. S., Gibson, B. W., Engstrom, J. J., Zhou, D., and Apicella, M. A. (1995) Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect. Immun. 63, 2508–2515.
Stojiljkovic, I., Hwa, V., Larson, J., Lin, L., So, M., and Nassif, X. (1997) Cloning and characterization of the Neisseria meningitidis rfaC gene encoding α-1,5 heptosyltransferase I. FEMS Microbiol. Lett. 151, 41–49.
Jennings, M. P., Bisercic, M., Dunn, K. L. R., Virji, M., Martin, A., Wilks, K. E., et al. (1995) Cloning and molecular analysis of the lsi1 (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells. Microb. Pathog. 19, 391–407.
Koplow, J. and Goldfine, H. (1974) Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli. J. Bacteriol. 117, 527–543.
Steeghs, L., Jennings, M. P., Poolman, J. T., and van der Ley, P. (1997) Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis. Gene 190, 263–270.
Karow, M., Fayet, O., Cegielska, A., Ziegelhoffer, T., and Georgopoulos, C. (1991) Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33°C in rich media. J. Bacteriol. 173, 741–750.
Westphal, O. and Jann, J. K. (1965) Bacterial lipopolysaccharide extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5, 83–91.
Tsai, C. M. and Frasch, C. E. (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119, 115–119.
Jennings, M. P., Srikhanta, Y. N., Moxon, E. R., Kramer, M., Poolman, J. T., Kuipers, B., and van der Ley, P. (1999) The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology 145, 3013–3021.
Goodman, S. D. and Scocca, J. J. (1988) Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. USA 85, 6982–6986.
Monod, M., Denoya, C., and Dubnau, D. (1986) Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J. Bacteriol. 167, 138–147.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
van der Ley, P., Steeghs, L. (2001). Construction of LPS Mutants. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:155
Download citation
DOI: https://doi.org/10.1385/1-59259-148-5:155
Publisher Name: Humana Press
Print ISBN: 978-0-89603-801-1
Online ISBN: 978-1-59259-148-0
eBook Packages: Springer Protocols